Apolipoprotein E and change in episodic memory in blacks and whites

Area of Science:

• Neuroscience
• Genetics
• Epidemiology

Background:

• Apolipoprotein E (APOE) ε4 is a known risk factor for cognitive decline, particularly in White populations.
• The impact of APOE ε4 on cognitive decline in Black populations remains less understood.
• Episodic memory decline is a key concern in aging and neurodegenerative diseases.

Purpose of the Study:

• To investigate the association between the APOE ε4 allele and the rate of episodic memory decline in Black individuals.
• To compare the effects of APOE ε4 on cognitive decline between Black and White participants.

Main Methods:

• Analysis of data from two similar cohort studies involving 1,211 participants without dementia at baseline.
• Participants underwent annual clinical evaluations for up to 6 years, with summary measures of 5 cognitive abilities derived from 18 neuropsychological tests.
• Mixed-effects models were used to control for demographic factors and examine the interaction of race and APOE ε4 status on cognitive decline.

Main Results:

• APOE ε4 was associated with faster decline in episodic memory and four other cognitive abilities in the overall sample.
• No significant racial differences were observed in the effect of APOE ε4 on episodic memory, perceptual speed, or visuospatial ability decline.
• The effect of APOE ε4 differed for semantic and working memory, with faster decline observed in White individuals but not in Black individuals.

Conclusions:

• The findings suggest that APOE ε4 similarly accelerates episodic memory decline in both Black and White individuals.
• Racial differences in the impact of APOE ε4 were noted for semantic and working memory, with a more pronounced effect in Whites.
• These results highlight the importance of considering genetic factors like APOE ε4 in the context of racial disparities in cognitive aging.